How to Document Genetic Counseling Sessions and Risk Assessments

A practical guide for certified genetic counselors on documenting genetic counseling sessions and risk assessments. Covers three-generation pedigree documentation, risk model records, variant interpretation, informed consent, pre-test and post-test counseling notes, results disclosure, cascade testing coordination, insurance pre-authorization, CPT billing, and documenting patient understanding of probabilistic information.

Why Genetic Counseling Documentation Is Different

Most clinicians document what they observed, what they did, and what they plan to do next. Genetic counselors do all of that, and then they document something harder: what a patient understood about a probability. A risk estimate is not a diagnosis. A variant of uncertain significance is not a finding that points clearly toward treatment. And a cascade testing recommendation affects people who were never in the room.

That complexity creates documentation demands that general clinical note formats do not address well. A SOAP note structure will hold most of what happened in a genetic counseling session, but it will miss the pedigree, the risk model inputs and outputs, the variant classification rationale, the patient's stated comprehension of probabilistic language, and the downstream coordination tasks that follow a positive result. Each of those elements has clinical, legal, and billing consequences.

This guide covers the documentation components specific to genetic counseling practice: from the three-generation family history through risk model records, variant interpretation, informed consent, pre- and post-test counseling, results disclosure, and cascade testing coordination. It includes fictional examples showing documentation for a hereditary cancer risk session and a prenatal counseling session.

Documenting the Three-Generation Pedigree

The three-generation pedigree is the foundation of every genetic counseling record. It is not optional, and it is not a diagram that exists only in the counselor's head. It must be documented in a format that another clinician can read and interpret independently.

What to Capture in the Pedigree Record

The pedigree must include, at minimum:

All first-degree relatives (parents, siblings, children) with age, vital status, and relevant diagnoses
All second-degree relatives (grandparents, aunts, uncles, half-siblings) with the same information where known
Third-degree relatives when relevant to the hereditary pattern under investigation
Age of onset for each diagnosis, not just diagnosis name
Bilateral tumors or multiple primaries, noted specifically (e.g., bilateral breast cancer rather than "breast cancer x2")
Ethnic background of all four grandparents, documented because population-based carrier frequencies differ substantially by ancestry
Source of information for each data point: patient report, medical records review, or death certificate

When a patient cannot provide complete family history, document what information was unavailable, why (e.g., "patient adopted; no biological family history available"), and what alternative approaches were discussed to obtain records.

Pedigree Updates Between Sessions

If a patient returns with updated family history, document the additions as an amendment to the original pedigree, dated separately. Pedigree changes can alter risk estimates, and the record must show when information was received and how it affected clinical reasoning.

Risk Model Documentation

Genetic counselors routinely use validated computational models to estimate cancer risk, carrier probability, or other quantitative risk measures. The model, its inputs, and its outputs must all appear in the record. Documenting only the final percentage is not enough.

What to Document for Each Risk Model

BRCA1/2 mutation probability models such as BRCAPRO, Tyrer-Cuzick, and PREMM are commonly used for hereditary breast and ovarian cancer risk assessment. Lynch syndrome risk models (MMRpro, PREMM5) apply to colorectal and endometrial cancer contexts. Each model uses different input variables and produces different outputs.

For every model run, document:

Model name and version number
Inputs entered: affected relatives by relationship, age of onset, ancestry, tumor histology where applicable, prior test results
Output: lifetime risk estimate or mutation carrier probability, stated as a percentage or odds
How the estimate compares to average-population risk (gives context for patients and reviewers)
Clinical threshold used to guide testing recommendation (e.g., "NCCN criteria met" or "mutation probability exceeds 10% threshold")

Fictional Example: Hereditary Cancer Risk Session

Leticia R., a 38-year-old woman of Ashkenazi Jewish ancestry, presents for hereditary breast cancer risk assessment. Her mother was diagnosed with breast cancer at 42. Her maternal aunt had ovarian cancer at 56. Her maternal grandmother had an unknown cancer type in her 60s.

The counselor's note documents: "Tyrer-Cuzick v8.0 lifetime risk: 34.2% (average-population risk 12.3%). BRCAPRO mutation carrier probability: 18.7% for BRCA1, 6.4% for BRCA2. NCCN criteria met for BRCA1/2 testing based on Ashkenazi Jewish ancestry with first-degree relative breast cancer below age 50. Testing recommendation discussed and patient elected to proceed."

Without the model version and inputs, a future reviewer cannot verify whether the recommendation was appropriate given the information available at the time of the session.

Variant Interpretation Documentation

When genetic testing returns results, the counselor's record must document the classification of each variant reported and the clinical reasoning behind how that classification was communicated to the patient.

Classification Language

Use the five-tier ACMG/AMP classification system by name:

Pathogenic: Strong evidence that the variant causes disease
Likely pathogenic: Evidence favors disease causation; treated clinically as actionable
Variant of uncertain significance (VUS): Insufficient evidence to classify; treated as non-actionable for clinical decision-making
Likely benign: Evidence favors no disease causation
Benign: Strong evidence the variant does not cause disease

Document the classification tier, the gene involved, the specific variant notation in standard HGVS format (e.g., BRCA1 c.5266dupC), and the laboratory that issued the interpretation. Classification can change over time as evidence accumulates. The record date anchors which classification was in effect when clinical decisions were made.

Documenting VUS Communication

Variant of uncertain significance results are among the most difficult to communicate and document. The record must show:

That VUS was explained as a distinct category from pathogenic, not a weakly positive result
That clinical management was not changed based on VUS alone
That the patient was informed that reclassification is possible
Whether the laboratory has a recontact policy and whether the patient was given information about it
Patient's verbatim questions and the counselor's responses, or a brief summary if verbatim is not feasible

A note that says only "VUS explained" is not sufficient. Document the substance of the explanation.

Informed consent in genetics is a process, not a form. The signed consent document belongs in the chart, but the counseling record must also document the content of the consent conversation.

Elements to Document

The specific test or panel ordered and the laboratory performing it
The conditions or variants the test will and will not detect (analytical sensitivity and scope)
Possible result categories: positive/pathogenic, negative, VUS, and incidental findings if applicable
Implications of each result type for the patient and their biological relatives
Insurance implications discussed, including federal protections under GINA (Genetic Information Nondiscrimination Act) and the limitation that GINA does not apply to life, disability, or long-term care insurance
Patient's right to decline testing
Any secondary findings or incidental findings policy, especially for whole exome or genome sequencing
Confirmation that the patient had opportunity to ask questions before signing

Document whether a patient needed an interpreter, whether written materials were provided and at what literacy level, and whether the patient asked to take time before deciding.

Pre-Test Counseling Documentation

The pre-test session is often where the most substantive counseling occurs. The record for this session must capture more than clinical data.

Psychosocial Assessment in the Genetics Context

Psychosocial assessment in genetic counseling addresses how the patient is likely to respond to different possible results and what support structures are in place. Document:

Current emotional state and coping style as observed in the session
Prior experiences with cancer or genetic illness in the family and how the patient processed them
Motivation for testing: why now, and what the patient hopes to learn
How the patient has told family members about the appointment, if at all
Whether the patient has considered how a positive result would affect family relationships
Any signs of significant anxiety, depression, or decisional conflict that warrant referral before testing proceeds

This is not a full psychiatric evaluation. It is a targeted assessment of psychosocial readiness that informs how results should be delivered and what follow-up support to arrange.

Fictional Example: Prenatal Genetic Counseling

Marisol and David P. are referred for prenatal genetic counseling at 11 weeks gestation. Marisol is 36. An amniocentesis was offered due to advanced maternal age, and the couple requested information about cell-free fetal DNA (cfDNA) screening as an alternative.

The pre-test counseling note documents: "Couple presented together. Reviewed cfDNA as a screening test, not a diagnostic test. Detection rates and false positive rates for trisomy 21, 18, and 13 reviewed. Explained that a positive screen would require diagnostic confirmation via amniocentesis or CVS. Couple expressed preference for non-invasive screening with the understanding that a positive result would require further workup. David asked specifically about the detection rate for trisomy 18; counselor provided laboratory-specific data from the ordering lab's performance specifications. No decisional conflict noted. Couple elected cfDNA."

Post-Test Counseling and Results Disclosure Documentation

Results delivery in genetic counseling requires its own documentation structure. The record cannot simply state "results discussed."

What to Document at Results Disclosure

Date and method of results delivery (in-person, telephone, secure patient portal message)
Whether a support person was present or offered
The exact result and classification as reported by the laboratory
How the result was explained in lay terms
Patient's immediate emotional response, noted behaviorally (e.g., "patient became tearful," "patient requested clarification three times before stating she understood," "patient appeared relieved")
Patient's stated understanding of the result, in their own words where possible
Clinical management implications discussed: surveillance recommendations, risk-reducing interventions, referrals made
Whether the patient wanted written summary materials and whether they were provided

Documenting Patient Understanding of Probabilistic Information

Genetics results are probabilistic. A BRCA1 pathogenic variant does not guarantee cancer. A negative BRCA1/2 result does not eliminate risk. The record must show that the patient understood the difference between carrying a variant and having a diagnosis, and between a negative test result and a zero-risk result.

Document statements like: "Patient verbalized understanding that a 70% lifetime risk estimate means she may or may not develop cancer, not that cancer is inevitable" or "Patient correctly restated that a negative BRCA result reduces her risk estimate to population level but does not eliminate risk entirely." Brief return-demonstration documentation like this is defensible and clinically meaningful.

Cascade Testing Coordination Notes

When a patient tests positive for a pathogenic variant, the counselor's role extends to cascade testing: identifying at-risk relatives and facilitating their access to testing.

What to Document for Cascade Testing

Which relatives were identified as at risk, with their biological relationship to the proband
Whether the patient consented to share variant information with relatives
What materials were provided to facilitate family communication (family letters, laboratory variant-specific forms)
Any barriers the patient identified to family notification (estrangement, geographic distance, family member refusal)
Follow-up plan: whether the patient agreed to report back on family members who accessed testing
Any coordination with a relative's own provider, and whether an authorization to release information was obtained

Genetic counselors do not contact relatives directly without patient authorization. The record must show that boundaries around that authorization were respected.

Insurance Pre-Authorization Documentation

Prior authorization for genetic testing is common and the documentation you submit directly affects whether testing is approved. Keep a copy of the pre-authorization request and any supporting clinical narrative in the patient record.

Document:

The specific CPT code(s) requested and the corresponding ICD-10-CM diagnosis code(s) justifying testing
The clinical criteria used to support the request (e.g., NCCN guideline criteria met, specific family history thresholds documented)
The insurer's decision and date of decision
If denied, the grounds for denial and whether an appeal was filed
If testing proceeded without authorization (patient self-pay), document the financial counseling conversation and the patient's decision

Billing with CPT 96040 and 96041

Genetic counseling has two primary outpatient counseling CPT codes:

CPT 96040: Medical genetics and genetic counseling services, per 30 minutes. Used for the initial evaluation and for complex sessions.
CPT 96041: Each additional 30 minutes beyond the first, reported with 96040 as the base code.

For billing compliance, the record must document:

Total face-to-face time with the patient (not including charting or administrative tasks)
The content justifying the time billed: history taking, risk assessment, counseling activities performed
Whether a physician was involved in a shared visit or co-signed the encounter

Some payers require documentation that the counseling was provided by a board-eligible or certified genetic counselor (CGC). Know your payer contracts, and document credential information where required.

A structured visit note that includes all of the components above serves double duty: it is clinically defensible and it supports billing at the appropriate level. Some counselors use a template with dedicated fields for pedigree summary, risk model output, and counseling content to ensure nothing is omitted. Tools like NotuDocs let counselors pre-build that template structure so each field is ready to fill at the end of the session, without starting from a blank note each time.

Common Documentation Mistakes in Genetic Counseling

Documenting only the result, not the context. A note that reads "BRCA1 positive result discussed" is incomplete. Document what was said, how the patient responded, and what happens next.

Omitting the pedigree from the electronic record. Pedigrees drawn on paper during the session must be scanned or recreated in the record. A pedigree that exists only in the counselor's memory is not documented.

Using classification language imprecisely. "Inconclusive" and "uncertain" are not synonyms for VUS in the ACMG framework. Use the standard five-tier terminology.

Failing to document the risk model version. Models are updated. The version number anchors your documentation in time and allows future reviewers to assess whether the calculation used current evidence.

Treating cascade testing as complete when the letter was mailed. Document the patient's plan for family notification and any follow-up. A family letter mailed without follow-up is not cascade testing; it is a referral with no loop closure.

Conflating screening results with diagnostic results. In prenatal counseling especially, document clearly that cfDNA and other screening tests are not diagnostic, and that the patient understood this before testing.

Documentation Checklist for Genetic Counseling Sessions

Pedigree

Three-generation family history documented with ages, diagnoses, and age of onset
Ethnic background of all four grandparents noted
Information source documented for each data point
Updates dated separately from original pedigree

Risk Assessment

Model name and version number documented
All input variables listed
Output stated as a percentage with population-risk comparison
Clinical threshold or guideline criteria stated

Variant Interpretation

ACMG five-tier classification used by name
Variant in standard HGVS notation
Laboratory that issued the classification documented
VUS communication documented with substance, not just reference to "VUS explained"

Test scope and detection limits discussed
All result categories explained
GINA protections and limitations discussed
Incidental findings policy addressed if applicable
Patient's questions and opportunity to decline documented

Pre-Test Psychosocial Assessment

Emotional state and coping observed
Motivation for testing documented
Family communication and readiness assessed
Referral made or not made, with rationale

Results Disclosure

Date, method, and support person noted
Patient's emotional response documented behaviorally
Patient's stated understanding in own words
Management plan and referrals documented

Cascade Testing

At-risk relatives identified by relationship
Patient consent to share information documented
Materials provided documented
Follow-up plan stated

Billing

Face-to-face time documented
CPT 96040/96041 supported by session content
Pre-authorization status documented
Credential documentation included where payer requires it